1. Home
  2. TKR vs KRYS Comparison

TKR vs KRYS Comparison

Compare TKR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKR
  • KRYS
  • Stock Information
  • Founded
  • TKR 1899
  • KRYS 2015
  • Country
  • TKR United States
  • KRYS United States
  • Employees
  • TKR N/A
  • KRYS N/A
  • Industry
  • TKR Metal Fabrications
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TKR Industrials
  • KRYS Health Care
  • Exchange
  • TKR Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • TKR 5.1B
  • KRYS 4.3B
  • IPO Year
  • TKR N/A
  • KRYS 2017
  • Fundamental
  • Price
  • TKR $75.98
  • KRYS $150.27
  • Analyst Decision
  • TKR Buy
  • KRYS Strong Buy
  • Analyst Count
  • TKR 10
  • KRYS 11
  • Target Price
  • TKR $79.56
  • KRYS $205.27
  • AVG Volume (30 Days)
  • TKR 764.9K
  • KRYS 433.0K
  • Earning Date
  • TKR 07-30-2025
  • KRYS 08-04-2025
  • Dividend Yield
  • TKR 1.84%
  • KRYS N/A
  • EPS Growth
  • TKR N/A
  • KRYS 36.22
  • EPS
  • TKR 4.40
  • KRYS 4.91
  • Revenue
  • TKR $4,514,100,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • TKR N/A
  • KRYS $40.10
  • Revenue Next Year
  • TKR $3.23
  • KRYS $49.73
  • P/E Ratio
  • TKR $17.28
  • KRYS $30.64
  • Revenue Growth
  • TKR N/A
  • KRYS 116.08
  • 52 Week Low
  • TKR $56.20
  • KRYS $122.80
  • 52 Week High
  • TKR $87.52
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • TKR 49.11
  • KRYS 56.44
  • Support Level
  • TKR $73.02
  • KRYS $132.31
  • Resistance Level
  • TKR $80.41
  • KRYS $151.61
  • Average True Range (ATR)
  • TKR 2.38
  • KRYS 6.34
  • MACD
  • TKR -0.04
  • KRYS 0.36
  • Stochastic Oscillator
  • TKR 39.94
  • KRYS 69.37

About TKR Timken Company (The)

The Timken Co designs and manages a portfolio of engineered bearings and industrial motion products, and provides related services. The Company sells products and services to customers in the following market sectors: industrial distribution, renewable energy, automation, automotive original equipment (OE), agriculture/turf, rail, aerospace, auto/truck aftermarket, construction, etc. The company has two reportable segment: The Engineered Bearings portfolio features bearings with precision tolerances, proprietary internal geometries and quality materials. The Industrial Motion portfolio features products such as drives, breathers, seals, automatic lubrication systems, linear motion products, chain, belts, couplings, etc. Key revenue is generated from Engineered Bearings.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: